Pascaline Clerc-Brenner

Pascaline Clerc-Brenner is the Vice President of Global External Affairs at Inventiva Pharma. Pascaline has been with the company for 1 year and 4 months, leading the company's corporate and scientific communications, stakeholders engagement including patients, key opinion leaders & organizations, and market access activities. Prior to Inventiva Pharma, Pascaline was the Founder of Meliora Strategy, LLC, a DC-based science policy strategy & advisory firm whose clients have included bio-pharmaceutical and social impact technology companies, as well as trade associations. Pascaline was with the company for 3 years. Before Meliora Strategy, Pascaline was the Vice President, External Affairs US at GENFIT where they led NASH policy, advocacy and partnerships. Pascaline was with GENFIT for 1 year and 10 months. Prior to GENFIT, Pascaline was an AAAS Science & Technology Policy Fellow at the U.S. Department of the Interior where they supported policy analysis and development on Emergency Medical Services for all the National Parks and inter-agency work. Pascaline was with the AAAS for 1 year and 5 months. Pascaline has also been a Management Team Member at AltTox.org for 3 years and 10 months and Senior Director of Policy and Advocacy, Animal Research Issues at The Humane Society of the United States for 4 years and 4 months.

Pascaline Clerc-Brenner has a PhD from the Université Joseph Fourier (Grenoble I) in Biochemistry, cellular and molecular biology. Pascaline also has a Master from the University of Grenoble in Biochemistry, cellular and molecular biology. Pascaline completed their Bachelor at the Université de Franche-Comté in Biochemistry. During their studies, they were an active member of the association of PhD candidates 38Globule and the president of the University association for the PhD candidates (Globule38).